Tsuyoshi Ohta Selected Research

Tsuyoshi Ohta Research Topics

Disease

22	Neoplasms (Cancer) 01/2023 - 10/2005
15	Ovarian Neoplasms (Ovarian Cancer) 12/2022 - 05/2004
14	Stroke (Strokes) 04/2024 - 10/2013
6	Carcinoma (Carcinomatosis) 07/2023 - 05/2018
5	Ischemic Stroke 11/2023 - 07/2018
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 08/2015
5	Ascites 01/2015 - 05/2004
4	Aneurysm (Aneurysms) 04/2024 - 01/2022
3	Embolism (Embolus) 04/2024 - 02/2005
3	Intracranial Aneurysm (Cerebral Aneurysm) 03/2023 - 09/2016
3	Cerebral Hemorrhage 12/2022 - 10/2016
3	Hypertension (High Blood Pressure) 12/2022 - 10/2016
3	Delirium 01/2021 - 10/2013
3	Breast Neoplasms (Breast Cancer) 11/2005 - 10/2003
2	Cerebral Infarction 01/2022 - 01/2019
2	Endometrial Neoplasms (Endometrial Cancer) 01/2022 - 05/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2020 - 03/2016
2	Vasculitis (Vasculitides) 06/2020 - 11/2009
2	Phlebitis 07/2018 - 10/2016
2	Hypoxia (Hypoxemia) 01/2012 - 06/2008
1	Blood Vessel Dissection 04/2024
1	Carotid Stenosis (Carotid Artery Stenosis) 04/2024
1	Pathologic Constriction (Stenosis) 04/2024
1	Thrombosis (Thrombus) 04/2024
1	Brain Ischemia (Cerebral Ischemia) 11/2023
1	Ovarian Epithelial Carcinoma 07/2023
1	Open Bite (Openbite) 07/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Proteinuria 12/2022
1	Intestinal Perforation 12/2022
1	Hematoma 12/2022
1	Urinary Tract Infections (Urinary Tract Infection) 11/2022
1	Pneumonia (Pneumonitis) 11/2022
1	Hypotension (Low Blood Pressure) 03/2022
1	Glioma (Gliomas) 03/2022
1	Septic Shock (Toxic Shock Syndrome) 02/2022
1	COVID-19 01/2022
1	Rupture 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Endometrioid Carcinoma 01/2022
1	Varicose Veins (Varicose Vein) 01/2021
1	Heart Failure 01/2021

Drug/Important Bio-Agent (IBA)

9	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 05/2004
7	Paclitaxel (Taxol)FDA LinkGeneric 07/2023 - 11/2004
5	PlatinumIBA 12/2022 - 11/2009
4	fasudil (AT 877)IBA 11/2023 - 05/2007
4	Bevacizumab (Avastin)FDA Link 12/2022 - 10/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2015 - 05/2007
4	Estrogens (Estrogen)FDA Link 07/2013 - 10/2003
3	Carboplatin (JM8)FDA LinkGeneric 11/2020 - 03/2016
3	taxaneIBA 08/2017 - 01/2016
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2006 - 09/2005
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2023 - 07/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 12/2020
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2022 - 09/2020
2	AntioxidantsIBA 01/2022 - 09/2020
2	Glutathione (Reduced Glutathione)IBA 01/2022 - 09/2020
2	Clopidogrel (Plavix)FDA Link 01/2021 - 09/2016
2	ramelteon (Rozerem)FDA Link 01/2019 - 10/2013
2	Nicardipine (Dagan)FDA LinkGeneric 07/2018 - 10/2016
2	Estradiol (Delestrogen)FDA LinkGeneric 09/2017 - 07/2013
2	Irinotecan (Camptosar)FDA LinkGeneric 08/2017 - 07/2007
2	NF-kappa B (NF-kB)IBA 11/2005 - 11/2004
2	Raloxifene Hydrochloride (Evista)FDA Link 12/2004 - 10/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2004 - 10/2003
2	BAY 11-7085IBA 11/2004 - 05/2004
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Prothrombin (Factor II)IBA 12/2022
1	Vitamin K FDA Link 12/2022
1	prothrombin complex concentrates (PPSB)IBA 12/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2022
1	AcidsIBA 03/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	BenzodiazepinesIBA 01/2021
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2021

Therapy/Procedure

15	Therapeutics 11/2023 - 08/2008
10	Drug Therapy (Chemotherapy) 07/2023 - 11/2009
7	Thrombectomy 04/2024 - 04/2018
6	Stents 04/2024 - 09/2004
3	Aftercare (After-Treatment) 07/2023 - 02/2019
3	Combination Drug Therapy (Combination Chemotherapy) 11/2019 - 07/2007
2	Operative Surgical Procedures 04/2024 - 11/2009
2	Radiotherapy 01/2023 - 11/2019
2	Adjuvant Chemotherapy 01/2023 - 03/2016
2	Punctures 01/2022 - 11/2009
2	Hysterectomy 12/2021 - 03/2016
2	Trachelectomy 08/2015 - 08/2015
1	Cerebral Revascularization 04/2024
1	Embolic Protection Devices 04/2024
1	Early Ambulation 07/2023
1	Catheters 01/2023
1	Retreatment 08/2022
1	Controlled Hypotension 03/2022
1	Cesarean Section (Caesarean Section) 02/2022
1	Salvage Therapy 01/2022
1	Minimally Invasive Surgical Procedures 12/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021